Bioventus Inc. (BVS) Tops Q1 EPS by 5c ; Offers Guidance

Bioventus Inc. (NASDAQ: BVS) reported Q1 EPS of $0.15, $0.05 better than the analyst estimate of $0.10. Revenue for the quarter came in at $132.1 million versus the consensus estimate of $129.86 million.

GUIDANCE:

Bioventus Inc. sees FY2026 EPS of $0.75-$0.79, versus the consensus of $0.75.

For earnings history and earnings-related data on Bioventus Inc. (BVS) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Ross Stores (ROST) call put ratio 1 call to 1 put as share price down 3%
• Johnson Controls (JCI) 4K contracts of August 120 puts trade, share price down 4%